Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 28, 2026
Why Is ProShares Ultra VIX Short-Term Futures ETF (UVXY) Up +3.44% Today?

Why Is ProShares Ultra VIX Short-Term Futures ETF (UVXY) Up +3.44% Today?

Key Takeaways

  • UVXY climbed +3.44% to approximately $17.43, up from a prior close of $16.85.
  • The advance tracked a sharp rise in the Cboe Volatility Index (VIX), which surged roughly 8–10% above the 16 level to start the week.
  • Primary catalyst: escalating U.S.–Iran tensions and renewed concerns over the Strait of Hormuz after a proposed peace roadmap was rejected.
  • Secondary drivers: surging crude oil prices and multi-year highs in U.S. Treasury yields, which fueled a broad risk-off tone.
  • As a leveraged volatility product, UVXY amplifies daily moves in short-term VIX futures rather than tracking individual stocks.
  • Investors are watching whether the VIX breaks above key thresholds and whether geopolitical headlines continue to pressure equities.

Opening Summary

The UVXY ProShares Ultra VIX Short-Term Futures ETF advanced +3.44% in Monday's session, rising from a prior close of $16.85 to roughly $17.43. The fund seeks to deliver 1.5 times the daily performance of the S&P 500 VIX Short-Term Futures Index, giving traders leveraged exposure to expected equity-market volatility. The move higher confirmed a risk-off repricing across financial markets, as the underlying VIX jumped from its Friday close of about 14.88 toward the 16 area amid renewed geopolitical uncertainty.

What Drove the ETF Move Today

Geopolitical Risk and the Strait of Hormuz

The strongest catalyst behind the ETF rally was a flare-up in U.S.–Iran tensions. Reports that Washington rejected an Iranian proposal to reopen the Strait of Hormuz and restart negotiations revived concerns about potential disruptions to a critical global oil shipping route. Heightened geopolitical uncertainty is a classic driver of implied volatility, pushing the VIX higher and lifting volatility-linked funds such as UVXY.

Surging Crude Oil Prices

The geopolitical headlines sent energy markets higher, with Brent crude climbing above $106 per barrel and WTI above $94. Rising oil prices reinforced the risk-off mood by raising concerns about inflation, corporate costs, and the potential for further supply disruptions. Because oil-price shocks tend to raise uncertainty around the growth outlook, they added fuel to the volatility complex.

Rising Treasury Yields and Risk-Off Sentiment

Investor sentiment was further pressured by a continued climb in U.S. Treasury yields. The benchmark 10-year yield hovered above 5.2%, near multi-decade highs, while the 30-year yield pushed toward 5.5%. Higher yields weigh on equity valuations and can trigger portfolio hedging activity, contributing to the demand for volatility exposure that underpinned the move in UVXY.

Which Holdings Contributed Most

UVXY does not hold individual stocks. Instead, its exposure is built from a portfolio of short-dated VIX futures contracts that roll forward on an ongoing basis. Today's gain was therefore driven almost entirely by the repricing of those futures rather than any single equity. Because the fund applies 1.5x leverage that resets daily, its percentage move exceeded the underlying index's move, amplifying the VIX advance. Investors should note that this same leverage and the cost of rolling futures contracts can erode long-term returns during calm markets.

Market Context and Trading Activity

The advance in UVXY aligned with a broad repricing of volatility across asset classes. U.S. stock futures pointed lower to start the week, with the Nasdaq-100 leading declines, while global equity benchmarks in Asia came under pressure. The move reflected a market reaction to elevated crude prices, surging bond yields, and thin equity market breadth rather than a single company-specific event. The VIX's climb above 16 marked a break from the low-volatility regime that had prevailed into the prior week, though the index remained well below the 20 threshold typically associated with elevated market stress.

What Comes Next for UVXY

The near-term path for UVXY will depend heavily on whether volatility expectations continue to climb. Key factors investors should monitor include further developments in U.S.–Iran negotiations, oil-price direction, and whether Treasury yields extend their advance. A sustained break higher in the VIX could support additional gains in the fund, while a de-escalation of geopolitical tensions or a stabilization in yields could unwind volatility quickly. Given the fund's leveraged structure and the persistent effects of futures-contract roll costs, its returns over multiple sessions can diverge substantially from the spot VIX, making it a product suited primarily to short-term, tactical positioning rather than long-term holding.

Trending AI Robots

Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, allowing users to explore approaches aligned with their own objectives. Investors seeking data-driven tools to navigate fast-moving volatility products may find this selection a useful starting point.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UVXY

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for UVXY turns negative, indicating new downward trend

UVXY saw its Momentum Indicator move below the 0 level on September 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 77 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UVXY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for UVXY entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UVXY's RSI Oscillator exited the oversold zone, 42 of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for UVXY just turned positive on September 08, 2026. Looking at past instances where UVXY's MACD turned positive, the stock continued to rise in 39 of 46 cases over the following month. The odds of a continued upward trend are 85%.

Following a +3.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where UVXY advanced for three days, in 172 of 195 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

UVXY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the performance of the S&P 500 VIX Short-Term Futures Index for a single day. The index seeks to offer exposure to market volatility through publicly traded futures markets and is designed to measure the implied volatility of the S&P 500 over 30 days in the future.
View a ticker or compare two or three
UVXY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Miscellaneous
Address
ProShares Trust II7501 WISCONSIN AVEBethesda
Phone
240-497-6400
Web
www.proshares.com
Interact to see
Advertisement
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.
AUGO shares are trading roughly 9% higher in Wednesday action, moving from a prior close of $66.42 to around $72.40 intraday. The stock’s advance extends a powerful year-long rally underpinned by record 2025 production, surging Adjusted EBITDA, and a recently declared cash dividend of $0.66 per share.
NAVN shares are surging approximately +25% in premarket trading on March 26, 2026, following a blockbuster earnings report released after the close of the prior session. Primary catalyst: Q4 fiscal year 2026 results delivered a significant beat — revenue of $178 million rose 35% year-over-year, surpassing analyst forecasts by nearly 10%.
OLPX surged approximately +50.38% in premarket trading on March 26, 2026, from a previous close of $1.33 to approximately $2.00, with an intraday premarket high of $2.03. The primary catalyst is a definitive acquisition agreement by German consumer goods giant Henkel AG to purchase Olaplex for $2.06 per share in an all-cash deal, valuing the company at approximately $1.4 billion.
TASK shares are down approximately -36% in premarket trading on March 26, 2026, the stock's official ex-dividend date for its special $3.65 per share cash dividend. The $3.65 special cash dividend — exceeding 25% of the stock's pre-ex-div market value — triggered a mandatory Nasdaq-prescribed price adjustment on today's open.
MLKN shares are down approximately 18.90% in premarket trading on March 26, 2026, falling to $15.70 from the prior session's close of $19.36. The primary catalyst is a double miss on both earnings and revenue in the company's fiscal Q3 2026 report released after the close on March 25.
Wave Life Sciences (WVE) shares are tumbling approximately 51% in premarket trading on March 26, 2026, from a prior close of $12.30 to approximately $6.03. The primary catalyst is the release of highly anticipated INLIGHT Phase 1 clinical data for WVE-007, the company's investigational INHBE GalNAc-siRNA obesity treatment, with results falling materially short of investor expectations.
APP is trading approximately 6% lower in premarket trading on March 26, 2026, extending a multi-session losing streak. The prior regular-session close (March 25, 2026) stood at $435.91, itself already down 5.02% from the day before, making the premarket slide a continuation of accelerating selling pressure.
KOD shares surged approximately +50% in premarket trading on Thursday, March 26, 2026, from a prior closing price of $22.75 to approximately $34.13. The primary catalyst is a landmark readout: the GLOW2 Phase 3 trial of Zenkuda (tarcocimab tedromer) in diabetic retinopathy met its primary endpoint with overwhelming statistical significance.